Non-HDL cholesterol and long-term follow-up outcomes in patients with metabolic syndrome

BACKGROUND: Non-high-density lipoprotein-cholesterol (non-HDL-C) has been identified as a potential biomarker for metabolic syndrome (MetS). However, its predictive capability for MetS varies among different ethnic groups, necessitating further investigation. This study aimed to assess the role of n...

Descripción completa

Detalles Bibliográficos
Autores principales: Vazirian, Fatemeh, Darroudi, Susan, Rahimi, Hamid Reza, Latifi, MohamadReza, Shakeri, Behrouz, Abolbashari, Samaneh, Mohammadpour, Amir Hooshang, Esmaily, Habibollah, Mouhebati, Mohsen, Samadi, Sara, Mobarhan, Majid Ghayour
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548659/
https://www.ncbi.nlm.nih.gov/pubmed/37794473
http://dx.doi.org/10.1186/s12944-023-01923-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548659/
https://www.ncbi.nlm.nih.gov/pubmed/37794473
http://dx.doi.org/10.1186/s12944-023-01923-y

Ejemplares similares